Intellia Therapeutics, Inc.
GB ˙ LSE ˙ US45826J1051
14,82 USD ↑1,89 (14,61%)
2026-06-04
CENA AKCJI
SecurityGB:0JBU / Intellia Therapeutics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership2,689,486 shares
Latest Disclosed Value $ 34,479,209
UBS Group AG ownership in 0JBU / Intellia Therapeutics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 2,689,486 shares of Intellia Therapeutics, Inc. (GB:0JBU) valued at $34,301,973 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 859,552 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 212.89% during the quarter. The current value of the position is $39,858,183 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (0JBU) in the form of stock options. The firm currently holds call options representing 568,772 of underlying shares valued at $7,291,657 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0JBU / Intellia Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 2,689,486 1,829,934 212.89 34,479 346.21 0.0010
2026-01-29 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 859,552 -248,634 -22.44 7,727 -59.62 0.0013
2025-11-13 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,108,186 227,313 25.81 19,138 131.64 0.0030
2025-08-14 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 880,873 -245,931 -21.83 8,263 3.13 0.0014
2025-05-13 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,126,804 -614,964 -35.31 8,012 -60.55 0.0015
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,741,768 1,463,336 525.56 20,309 254.99 0.0038
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 278,432 22,881 8.95 5,722 0.03 0.0012
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 255,551 -76,035 -22.93 5,719 -37.30 0.0014
2024-05-13 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 331,586 57,062 20.79 9,122 8.97 0.0023
2024-02-09 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 274,524 150,517 121.38 8,370 113.47 0.0025
2023-11-09 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 124,007 -10,862 -8.05 3,921 -28.70 0.0014
2023-08-11 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 134,869 45,495 50.90 5,500 65.14 0.0019
2023-05-12 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 89,374 -92,237 -50.79 3,331 -47.44 0.0012
2023-02-08 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 181,611 132,643 270.88 6,336 131.16 0.0024
2022-11-10 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 48,968 2,054 4.38 2,741 12.84 0.0012
2022-08-10 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 46,914 -52,265 -52.70 2,429 -66.30 0.0010
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 99,179 -15,969 -13.87 7,208 -47.06 0.0024
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 115,148 50,694 78.65 13,615 57.45 0.0039
2021-11-15 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 64,454 15,039 30.43 8,647 8.07 0.0027
2021-08-13 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 49,415 -2,696 -5.17 8,001 91.32 0.0026
2021-05-12 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 52,111 -73,838 -58.63 4,182 -38.97 0.0014
2021-02-11 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 125,949 50,413 66.74 6,852 356.50 0.0023
2020-11-12 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 75,536 -10,204 -11.90 1,501 -16.70 0.0006
2020-07-31 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 85,740 4,071 4.98 1,802 80.38 0.0008
2020-05-01 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 81,669 -33,065 -28.82 999 -40.64 0.0005
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 114,734 -110,980 -49.17 1,683 -44.16 0.0006
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 225,714 71,391 46.26 3,014 19.32 0.0012
2019-08-14 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 154,323 13,187 9.34 2,526 4.77 0.0010
2019-05-14 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 141,136 -63,465 -31.02 2,411 -13.68 0.0010
2019-02-14 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 204,601 66,702 48.37 2,793 -29.22 0.0013
2018-11-14 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 137,899 16,994 14.06 3,946 19.29 0.0016
2018-08-14 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 120,905 -70,711 -36.90 3,308 -18.14 0.0014
2018-05-15 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 191,616 108,878 131.59 4,041 153.99 0.0017
2018-02-14 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 82,738 13,114 18.84 1,591 -8.03 0.0007
2017-11-14 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 69,624 7,320 11.75 1,730 73.52 0.0008
2017-11-14 2017-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 62,304 1,369 2.25 997 16.07 0.0005
2017-08-14 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 62,304 1,369 997
2017-11-14 2017-03-31 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 60,935 49,480 431.95 859 472.67 0.0005
2017-05-12 2017-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 60,935 49,480 859
2017-02-14 2016-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 11,455 10,038 708.40 150 525.00 0.0001
2016-11-14 2016-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,417 417 41.70 24 14.29 0.0000
2016-08-12 2016-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,000 1,000 21 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-05 2026-03-31 13F INTELLIA THERAPEUTICS COM Call 568,772 50.40 7,292 114.50 n/a n/a n/a
2026-01-29 2025-12-31 13F INTELLIA THERAPEUTICS COM Call 378,184 -23.73 3,400 -60.31 n/a n/a n/a
2025-11-13 2025-09-30 13F INTELLIA THERAPEUTICS COM Call 495,876 106.01 8,564 279.40 n/a n/a n/a
2025-08-14 2025-06-30 13F INTELLIA THERAPEUTICS COM Call 240,709 2,258 n/a n/a n/a
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM Call 18,648 383 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-08-10 2022-06-30 13F INTELLIA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F INTELLIA THERAPEUTICS COM Put 34,000 2,471 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.